Showing results (291-300 of 319) with videos related to
Sort By:
Pageof 32
British Journal of Haematology|September 30, 2017
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trialHermann Einsele, Monika Engelhardt, Christoph Tapprich, et al.Annals of Hematology|August 1, 2020
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysisM Pouyiourou, A Meyer, A Stroux, et al.Mycoses|August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.European Journal of Immunology|December 9, 2020
Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situPatrick Maschmeyer, Gitta Anne Heinz, Christopher Mark Skopnik, et al.Antimicrobial Agents and Chemotherapy|June 7, 2017
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with NeutropeniaCarlota Gudiol, Cristina Royo-Cebrecos, Edson Abdala, et al.Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.BMJ Open|January 25, 2017
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)C Gudiol, C Royo-Cebrecos, C Tebe, et al.Nature Immunology|February 20, 2019
c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host-microbiota homeostasisChristian Neumann, Jonas Blume, Urmi Roy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study GroupMichael Fuchs, Helen Goergen, Carsten Kobe, et al.Frontiers in Oncology|April 7, 2023
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trialSusanne Wiegand, Gunnar Wichmann, Jeannette Vogt, et al.Pageof 32